Clinical Trial Update: Cerebrovascular Reactivity in Alzheimer's Disease

View source ↗

Summary

This clinical trial update notes that the study evaluating cerebrovascular reactivity in Alzheimer's disease and subjective cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Subjective Cognitive Impairment

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer Disease, Subjective Cognitive Impairment | Status: COMPLETED